Adam D. Cutler's most recent trade in Mural Oncology plc was a trade of 65,000 Stock Option (right to buy) done . Disclosure was reported to the exchange on March 3, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Mural Oncology plc | Adam D. Cutler | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2025 | 65,000 | 65,000 | - | - | Stock Option (right to buy) | |
| Mural Oncology plc | Adam D. Cutler | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2025 | 35,000 | 106,438 | - | 0 | Ordinary Shares | |
| Mural Oncology plc | Adam D. Cutler | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 3.41 per share. | 31 Oct 2024 | 7,421 | 71,438 | - | 3.4 | 25,306 | Ordinary Shares |
| Mural Oncology plc | Adam D. Cutler | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Dec 2023 | 146,452 | 146,452 | - | - | Stock Option (right to buy) | |
| Mural Oncology plc | Adam D. Cutler | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Dec 2023 | 78,859 | 78,859 | - | 0 | Ordinary Shares | |
| InMed Pharmaceuticals Inc | Adam D. Cutler | Director | 24 Jan 2022 | 22,727 | 16,122 | - | - | Employee Stock Option (Expiration) | ||
| InMed Pharmaceuticals Inc | Adam D. Cutler | Director | 24 Jan 2022 | 6,061 | 40,364 | - | - | Employee Stock Option (Expiration) | ||
| InMed Pharmaceuticals Inc | Adam D. Cutler | Director | 24 Jan 2022 | 1,515 | 38,849 | - | - | Employee Stock Option (Expiration) | ||
| InMed Pharmaceuticals Inc | Adam D. Cutler | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Dec 2021 | 7,000 | 46,425 | - | - | Employee Stock Option (Right to Buy) | |
| Molecular Templates Inc | Adam D. Cutler | See remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Feb 2021 | 125,000 | 125,000 | - | - | Stock Option (right to buy) | |
| InMed Pharmaceuticals Inc | Adam D. Cutler | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Dec 2020 | 7,000 | 7,000 | - | - | Employee Stock Option (Right to Buy) |